Call of the wild: Singapore businesses still keen on emerging markets
Overseas trips, trade fairs set to resume despite pandemic hiatus, global uncertainties
Annabeth Leow
DeeperDive is a beta AI feature. Refer to full articles for the facts.
IT WAS late 2019, and Singapore biotech startup Stratificare was all set to begin clinical studies in partnership with experts in Mexico, for a test that might prove able to predict severe cases of dengue.
The tie-up arose from Stratificare's participation in a business delegation accompanying Prime Minister Lee Hsien Loong on his official visit to that country.
But the novel coronavirus hit – and that made it “very difficult for us to run any clinical study there”, Stratificare chief executive Anthony Chua told The Business Times.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant